- Report
- February 2026
- 92 Pages
Global
From €3500EUR$4,118USD£3,108GBP
- Report
- September 2026
- 197 Pages
Global
From €3228EUR$3,545USD£2,769GBP
€3586EUR$3,939USD£3,077GBP
- Report
- September 2026
- 185 Pages
Global
From €3228EUR$3,545USD£2,769GBP
€3586EUR$3,939USD£3,077GBP
- Report
- September 2026
- 185 Pages
Global
From €3228EUR$3,545USD£2,769GBP
€3586EUR$3,939USD£3,077GBP
- Report
- September 2026
- 185 Pages
Global
From €3228EUR$3,545USD£2,769GBP
€3586EUR$3,939USD£3,077GBP
- Report
- September 2026
- 184 Pages
Global
From €3228EUR$3,545USD£2,769GBP
€3586EUR$3,939USD£3,077GBP
- Report
- March 2026
- 80 Pages
China
From €4325EUR$4,750USD£3,710GBP
- Report
- September 2026
- 50 Pages
Global
From €2413EUR$2,650USD£2,070GBP
- Report
- September 2026
- 50 Pages
Global
From €2413EUR$2,650USD£2,070GBP
The Sodium Iodide market within the context of Animal Pharmaceuticals is a niche market that provides a range of products for the treatment of various animal diseases. These products are used to treat a variety of conditions, including thyroid disorders, hypothyroidism, and hyperthyroidism. Sodium Iodide is also used to treat iodine deficiency in animals, as well as to supplement iodine in animal feed.
The Sodium Iodide market is highly competitive, with a number of companies offering a variety of products. These companies include Merck Animal Health, Elanco Animal Health, Zoetis, Bayer Animal Health, and Virbac Animal Health. Each of these companies offers a range of products, including tablets, capsules, and injectables, to meet the needs of their customers. Show Less Read more